An eye doctor walks through the evidence on GLP-1 shots and vision, the rare warning signs to watch for and when to get urgent care.
Recap by typeshit. Post by @drhalmuhtaseb on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Novo's preprint covers 10,052 trial patients and ties semaglutide to organ ages one to four years younger, but none of it is peer reviewed yet.
An early animal result for the drug behind Ozempic and Wegovy. Researchers stress these were mice, so nothing yet says the same holds for people.
Loading…